ivabradine has been researched along with Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kavtaradze, N; Saganelidze, K | 1 |
| Arboscello, E; Balbi, M; Bighin, C; Brunelli, C; Ghigliotti, G; Gualandi, F; Murialdo, R; Sarocchi, M; Sicbaldi, V; Spallarossa, P | 1 |
| Armenian, SH; Ehrhardt, MJ; Fulbright, JM | 1 |
1 review(s) available for ivabradine and Neoplasms
| Article | Year |
|---|---|
[MODERN ASPECTS OF DIAGNOSIS AND TREATMENT OF HEART FAILURE, AS A MANIFESTATION OF ANTHRACYCLINE CARDIOTOXICITY (REVIEW)].
Topics: Anthracyclines; Antineoplastic Agents; Biomarkers; Cardiomyopathies; Cardiotonic Agents; Cardiotoxicity; Echocardiography; Elapid Venoms; Heart; Heart Failure; Humans; Ivabradine; Natriuretic Peptide, C-Type; Neoplasms; Survival Analysis; Trastuzumab; Trimetazidine; Troponin I | 2018 |
2 other study(ies) available for ivabradine and Neoplasms
| Article | Year |
|---|---|
Ivabradine in Cancer Treatment-Related Left Ventricular Dysfunction.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anthracyclines; Cardiovascular Agents; Dose-Response Relationship, Drug; Fatigue; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Neoplasms; Retrospective Studies; Trastuzumab; Ventricular Dysfunction, Left | 2018 |
Screening and intervention for treatment-related cardiac dysfunction in childhood cancer survivors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Biomarkers; Cardiovascular Diseases; Child; Echocardiography; Guidelines as Topic; Humans; Ivabradine; Neoplasms; Survivors; Troponin I; Troponin T | 2015 |